Dr. Paul Auerbach is the world's leading outdoor health expert. His blog offers tips on outdoor safety and advice on how to handle wilderness emergencies.See all posts »
Plasmodium falciparum Malaria and Artemisinin Resistance
Falciparum malaria can be a deadly disease, and is a scourge of mankind. Artemisinin-based combination drug therapies are recommended first-line treatments for falciparum malaria in all countries with endemic malaria. However, it has been observed that the effectiveness of such treatments has declined on the border between Thailand and Cambodia. If this is the case, the resistance will likely spread.
In an article (New England Journal of Medicine 2009;361:455-67) entitled "Artemisinin Resistance in Plasmodium falciparum Malaria," Arjen Dondorp, MD and colleagues compared the effectiveness of two treatments for uncomplicated falciparum malaria in western Cambodia and northwestern Thailand. The conclusion was that P. falciparum is not as susceptible (as measured by parasite clearance from the bloodstream) to artesunate in western Cambodia as in northwestern Thailand. The implications are very important. At least one very important approach should be entertained in this situation - a containment strategy - to try to limit the spread of the disease by controlling the affected mosquito population. Since artemisinin administration is replacing quinine as a primary therapy, resistance to this drug would be disastrous to control of malaria worldwide.
Tags: malaria, artemisinin, drug resistance, wilderness medicine, outdoor medicine, healthline
Recent Blog Posts
Jul 01, 2013
In Advance of a Wildfire
Feb 11, 2013
Topical Ivermectin Lotion for Treating Head Lice
Feb 04, 2013
Public Health Interventions and Snowmobile Fatality Rates